Alpha 2.0
Login Register
» Articles » PMID: 30936073

Exosomal MiRNA Cargo As Mediator of Immune Escape Mechanisms in Neuroblastoma

Overview
Journal Cancer Res
Specialty Oncology
Date 2019 Apr 3
PMID 30936073
Citations 23
Authors
Thomas D Schmittgen
Affiliations
Soon will be listed here.
Abstract

Both natural killer (NK) cells and exosomes released from these cells induce tumor cell cytotoxicity by way of the cell killing proteins perforin and granzyme. TGFβ1 protein in the tumor microenvironment generates an immune escape mechanism rendering NK cells inactive. The tumor-suppressive miR-186 that is downregulated in neuroblastoma and in TGFβ-treated NK cells represses oncogenic proteins in neuroblastoma (MYCN and AURKA) and components of the TGFβ pathway. Restoration of miR-186 levels in neuroblastoma through NK cell-derived exosomes or by nanoparticle delivery reduces tumor burden, promotes survival, and restores the cell-killing abilities of NK cells, demonstrating the therapeutic potential of tumor-suppressive miRNAs in neuroblastoma..

Citing Articles

Exosomes-based liquid biopsy: An effective approach for drugs and therapeutics resistance screening in cancer.

Nyahatkar S, Kalele K J Liq Biopsy. 2025; 4:100144.

PMID: 40027144 PMC: 11863703. DOI: 10.1016/j.jlb.2024.100144.

Immunomodulatory properties of extracellular vesicles isolated from bone marrow of patients with neuroblastoma: role of PD-L1 and HLA-G.

Marimpietri D, Corrias M, Tripodi G, Gramignoli R, Airoldi I, Morandi F Front Immunol. 2024; 15:1469771.

PMID: 39512342 PMC: 11540764. DOI: 10.3389/fimmu.2024.1469771.

Exosomes are the mediators between the tumor microenvironment and prostate cancer (Review).

Wu Y, Wang X, Zeng Y, Liu X Exp Ther Med. 2024; 28(6):439.

PMID: 39355518 PMC: 11443591. DOI: 10.3892/etm.2024.12728.

Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules.

Hazrati A, Malekpour K, Khorramdelazad H, Rajaei S, Hashemi S Biomark Res. 2024; 12(1):35.

PMID: 38515166 PMC: 10958918. DOI: 10.1186/s40364-024-00580-2.

Integrative analysis of multi-omics data for discovery of ferroptosis-related gene signature predicting immune activity in neuroblastoma.

Hu J, Song F, Kang W, Xia F, Song Z, Wang Y Front Pharmacol. 2023; 14:1162563.

PMID: 37521469 PMC: 10373597. DOI: 10.3389/fphar.2023.1162563.

References
1.
Chen Y, Stallings R . Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res. 2007; 67(3):976-83. DOI: 10.1158/0008-5472.CAN-06-3667. View
2.
Otto T, Horn S, Brockmann M, Eilers U, Schuttrumpf L, Popov N . Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma. Cancer Cell. 2008; 15(1):67-78. DOI: 10.1016/j.ccr.2008.12.005. View
3.
Vanichapol T, Chutipongtanate S, Anurathapan U, Hongeng S . Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma. Biomed Res Int. 2018; 2018:1812535. PMC: 5845499. DOI: 10.1155/2018/1812535. View
4.
Seeger R, Brodeur G, Sather H, Dalton A, Siegel S, Wong K . Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985; 313(18):1111-6. DOI: 10.1056/NEJM198510313131802. View
5.
Neviani P, Wise P, Murtadha M, Liu C, Wu C, Jong A . Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms. Cancer Res. 2018; 79(6):1151-1164. PMC: 6428417. DOI: 10.1158/0008-5472.CAN-18-0779. View